TABLE 2.

Median Uptake of ¹⁷⁷Lu-DOTATOC and ¹⁷⁷Lu-DOTA-JR11 24 Hours After Injection

Treatment group	First PRRT cycle		Second PRRT cycle
	Tumor	Kidney	Tumor	Kidney
177Lu-DOTATOC	2.7 (2.4–2.9)	2.6 (2.0–2.7)	2.0 (1.8–2.3)	2.5 (2.3–4.2)
177Lu-DOTA-JR11	10.4 (9.3–10.9)	3.2 (2.8–3.6)	12.9 (9.9–14.0)	3.0 (2.9–3.5)

Data are percentage injected activity per milliliter, followed by IQR in parentheses.